Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients
CompletedOBSERVATIONAL
Enrollment
396
Participants
Timeline
Start Date
January 1, 2016
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2021
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG
Renin-Angiotensin System Inhibitor
All Listed Sponsors
lead
Chulalongkorn University
OTHER
NCT06382571 - Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients | Biotech Hunter | Biotech Hunter